Atom Investors »

Benitec Biopharma shares owned by Atom Investors

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $559k 53k 10.65

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Bio-techne Corporation (TECH)
Equinix (EQIX)
Broadcom (AVGO)
Scotts Miracle-gro Cl A (SMG)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
LKQ Corporation (LKQ)
Carlisle Companies (CSL)
Dianthus Therapeutics (DNTH)
Ameren Corporation (AEE)
Reliance Steel & Aluminum (RS)
Wright Express (WEX)
Celcuity (CELC)
H&R Block (HRB)

View all positions for Atom Investors

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Simplify Asset Management
Vanguard Capital Management
Infinitum Asset Management
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management
Geode Capital Management

View all funds holding Benitec Biopharma